Extendicare Inkomsten in het verleden

Verleden criteriumcontroles 5/6

Extendicare is de winst gegroeid met een gemiddeld jaarlijks percentage van 15.8%, terwijl de Healthcare industrie de winst jaarlijks groeide met 16.2%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 4.6% per jaar. Het rendement op eigen vermogen van Extendicare is 56.2%, en het heeft een nettomarge van 4.5%.

Belangrijke informatie

15.8%

Groei van de winst

17.8%

Groei van de winst per aandeel

Healthcare Groei van de industrie	-6.7%
Inkomstengroei	4.6%
Rendement op eigen vermogen	56.2%
Nettomarge	4.5%
Laatste winstupdate	30 Sep 2024

Recente prestatie-updates uit het verleden

Shareholders Can Be Confident That Extendicare's (TSE:EXE) Earnings Are High Quality

Nov 19

Recent updates

Shareholders Can Be Confident That Extendicare's (TSE:EXE) Earnings Are High Quality

Nov 19

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Mar 16

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Oct 19

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Sep 21

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Aug 24

Extendicare's (TSE:EXE) Dividend Will Be CA$0.04

Jul 20

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Jun 20

Extendicare (TSE:EXE) Has Affirmed Its Dividend Of CA$0.04

May 18

Is Extendicare (TSE:EXE) Using Too Much Debt?

May 11

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Jan 20

Opbrengsten en kosten

Hoe Extendicare geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

TSX:EXE Opbrengsten, kosten en inkomsten (CAD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven
30 Sep 24	1,425	64	57
30 Jun 24	1,388	59	57
31 Mar 24	1,347	35	57
31 Dec 23	1,305	34	56
30 Sep 23	1,265	18	54
30 Jun 23	1,252	1	53
31 Mar 23	1,241	3	52
31 Dec 22	1,222	-5	51
30 Sep 22	1,217	-1	55
30 Jun 22	1,193	6	51
31 Mar 22	1,178	4	53
31 Dec 21	1,167	8	52
30 Sep 21	1,114	27	49
30 Jun 21	1,126	59	51
31 Mar 21	1,127	49	47
31 Dec 20	1,104	42	45
30 Sep 20	1,141	31	42
30 Jun 20	1,127	2	41
31 Mar 20	1,129	15	41
31 Dec 19	1,132	15	41
30 Sep 19	1,130	1	41
30 Jun 19	1,127	4	42
31 Mar 19	1,123	6	41
31 Dec 18	1,120	8	40
30 Sep 18	1,113	27	37
30 Jun 18	1,106	26	37
31 Mar 18	1,100	30	37
31 Dec 17	1,097	32	38
30 Sep 17	1,093	35	40
30 Jun 17	1,088	38	38
31 Mar 17	1,075	38	37
31 Dec 16	1,061	31	37
30 Sep 16	1,046	25	38
30 Jun 16	1,032	27	38
31 Mar 16	1,005	21	38
31 Dec 15	943	24	36
30 Sep 15	894	24	33
30 Jun 15	848	16	32
31 Mar 15	815	14	33
31 Dec 14	816	11	33
30 Sep 14	-118	2	7
30 Jun 14	183	4	16
31 Mar 14	480	9	26
31 Dec 13	784	10	37

Kwaliteitswinsten: EXE heeft hoge kwaliteitsinkomsten.

Groeiende winstmarge: De huidige netto winstmarges (4.5%) EXE } zijn hoger dan vorig jaar (1.4%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: De winst van EXE is de afgelopen 5 jaar met 15.8% per jaar gegroeid.

Versnelling van de groei: De winstgroei van EXE over het afgelopen jaar ( 261.9% ) overtreft het 5-jarig gemiddelde ( 15.8% per jaar).

Winst versus industrie: De winstgroei EXE over het afgelopen jaar ( 261.9% ) overtrof de Healthcare -sector 10.4%.

Rendement op eigen vermogen

Hoge ROE: Hoewel het rendement op eigen vermogen ( 56.21% ) van EXE uitstekend is, is deze metriek vertekend vanwege hun hoge schuldenniveau.

Extendicare Inkomsten in het verleden

Verleden criteriumcontroles 5/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Shareholders Can Be Confident That Extendicare's (TSE:EXE) Earnings Are High Quality

Third quarter 2024 earnings released: EPS: CA$0.20 (vs CA$0.14 in 3Q 2023)

Extendicare Inc. to Report Q3, 2024 Results on Nov 12, 2024

Second quarter 2024 earnings released: EPS: CA$0.30 (vs CA$0.023 in 2Q 2023)

Extendicare Inc. to Report Q2, 2024 Results on Aug 12, 2024

First quarter 2024 earnings released: EPS: CA$0.16 (vs CA$0.14 in 1Q 2023)

Recent updates

Shareholders Can Be Confident That Extendicare's (TSE:EXE) Earnings Are High Quality

Dividend of CA$0.04 announced

Third quarter 2024 earnings released: EPS: CA$0.20 (vs CA$0.14 in 3Q 2023)

Extendicare Inc. Declares Cash Dividend, Payable on December 16, 2024

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of October 2024, Payable on November 15, 2024

Extendicare Inc. to Report Q3, 2024 Results on Nov 12, 2024

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Dividend of CA$0.04 announced

Extendicare Inc. Announces Cash Dividend for the Month of September 2024, Payable on October 15, 2024

Extendicare's (TSE:EXE) Dividend Will Be CA$0.04

Dividend of CA$0.04 announced

Price target increased by 10% to CA$9.17

Second quarter 2024 earnings released: EPS: CA$0.30 (vs CA$0.023 in 2Q 2023)

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Dividend of CA$0.04 announced

Extendicare Inc. Announces July 2024 Cash Dividend, Payable on August 15, 2024

Extendicare Inc. to Report Q2, 2024 Results on Aug 12, 2024

Senior Vice President of ParaMed & CTO recently bought CA$98k worth of stock

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of June 2024, Payable on July 15, 2024

Extendicare (TSE:EXE) Is Paying Out A Dividend Of CA$0.04

Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A Director

Dividend of CA$0.04 announced

First quarter 2024 earnings released: EPS: CA$0.16 (vs CA$0.14 in 1Q 2023)

Extendicare Inc. Declares Cash Dividend for the Month of May 2024, Payable on June 17, 2024

Upcoming dividend of CA$0.04 per share

Extendicare Inc., Annual General Meeting, May 23, 2024

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of April 2024, Payable on May 15, 2024

Extendicare Inc. to Report Q1, 2024 Results on May 15, 2024

CEO, President & Director exercised options to buy CA$450k worth of stock.

Upcoming dividend of CA$0.04 per share

There May Be Underlying Issues With The Quality Of Extendicare's (TSE:EXE) Earnings

Price target increased by 10% to CA$8.00

Dividend of CA$0.04 announced

Full year 2023 earnings released: EPS: CA$0.40 (vs CA$0.051 loss in FY 2022)

Extendicare Inc. Declares Cash Dividend for the Month of March 2024, Payable on April 15, 2024

Upcoming dividend of CA$0.04 per share

Dividend of CA$0.04 announced

Extendicare Inc. Declares Cash Dividend for the Month of February 2024, Payable on March 15, 2024

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare Inc. to Report Q4, 2023 Results on Mar 07, 2024

Extendicare Inc. Declares Cash Dividend for the Month of December 2023, Payable on January 15, 2024

Independent Director recently bought CA$99k worth of stock

Upcoming dividend of CA$0.04 per share at 7.4% yield

Extendicare Inc. Declares Cash Dividend for the Month of November 2023, Payable on December 15, 2023

Third quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.049 loss in 3Q 2022)

Upcoming dividend of CA$0.04 per share at 7.9% yield

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of October 2023, Payable on November 15, 2023

Extendicare Inc. to Report Q3, 2023 Results on Nov 09, 2023

Upcoming dividend of CA$0.04 per share at 7.8% yield

Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.04

Extendicare Inc. Announces Cash Dividend for the September 2023, Payable on October 16, 2023

Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04

Upcoming dividend of CA$0.04 per share at 7.4% yield

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.039 in 2Q 2022)

Extendicare Inc. Declares Cash Dividend for the Month of August 2023, Payable on September 15, 2023

Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc.

Upcoming dividend of CA$0.04 per share at 6.5% yield

Extendicare's (TSE:EXE) Dividend Will Be CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of July 2023, Payable on August 15, 2023

Extendicare Inc. to Report Q2, 2023 Results on Aug 10, 2023

Upcoming dividend of CA$0.04 per share at 6.7% yield

Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.04

Extendicare Inc. Declares Cash Dividend for the Month of June 2023, Payable on July 17, 2023